0000899243-17-019847.txt : 20170808 0000899243-17-019847.hdr.sgml : 20170808 20170808175252 ACCESSION NUMBER: 0000899243-17-019847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170804 FILED AS OF DATE: 20170808 DATE AS OF CHANGE: 20170808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dylan-Hyde Tyler CENTRAL INDEX KEY: 0001682027 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 171015896 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-04 0 0001674416 CRISPR Therapeutics AG CRSP 0001682027 Dylan-Hyde Tyler C/O CRISPR THERAPEUTICS AG BAARERSTRASSE 14 6300 ZUG V8 SWITZERLAND 0 1 0 0 Chief Legal Officer Common Shares 2017-08-04 4 S 0 477 18.55 D 167727 D Common Shares 2017-08-07 4 S 0 13210 18.5624 D 154517 D Common Shares 2017-08-08 4 S 0 1313 18.5998 D 153204 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.55 to $18.92, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $18.82, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. /s/ Michael Esposito, attorney-in-fact 2017-08-08